A ‘Revolution’ in Cancer Research
AACR patient advocate forum explores how new clinical trial designs are accelerating drug testing.
AACR patient advocate forum explores how new clinical trial designs are accelerating drug testing.
The U.S. Food and Drug Administration approval provides a new option for patients who face a poor prognosis Onivyde,...
Study reports that alcohol, particularly white wine, consumption may be associated with higher risk for melanoma. A new study...
The U.S. Food and Drug Administration approval provides a new option for patients with the most deadly form of...
Cancer experts discuss the potential breakthroughs in cancer prevention, disparities, precision medicine, and immunotherapy in the coming year. What...
The U.S. Food and Drug Administration approval provides a new option for patients with the most common type of...
Tisotumab vedotin-tftv is approved to treat certain recurrent or metastatic cervical cancers. The U.S. Food and Drug Administration (FDA)...
Study suggests that germline genetics may influence lung cancer risk in this patient population. Native American ancestry was associated...
The U.S. Food and Drug Administration approval provides a new treatment option for patients whose cancer is not responding...
As the number of targeted cancer therapeutics has increased, the percentage of tumors carrying molecular alterations eligible for treatment...
The U.S. Food and Drug Administration (FDA) approval provides a new option for patients with a common type of...
The U.S. Food and Drug Administration approval provides a new option for patients with the most common type of...
A study finds that participation in clinical trials by African-Americans and Hispanics has declined over the last two decades....
The U.S. Food and Drug Administration approval means there are now three immunotherapeutics called checkpoint inhibitors approved for treating...
Adding the newly approved therapeutic to standard treatment improved survival for patients with advanced disease. The U.S. Food and...
Testing for chromosomal abnormalities and gene mutations helps to direct treatment for patients with AML.
The U.S. Food and Drug Administration action means ibrutinib is now an approved treatment for three types of non-Hodgkin...
A recent study found that an investigational HPV vaccine could prevent nearly 90 percent of cervical cancers. Human papillomavirus...
New cervical cancer screening guidelines emphasize the role of HPV testing, a study shows a steep decline in health...
The identification of two mutations that cause resistance to a next-generation therapy may lead to new treatment options for...
A recent study found that initial treatment with a checkpoint inhibitor was associated with increased median overall survival in...
A new molecularly targeted therapeutic to treat certain patients with follicular lymphoma, a common type of non-Hodgkin lymphoma, has...
Study presented at the AACR’s eighth annual cancer health disparities conference examines how improved diet reduced the risk of...
The FDA expanded the indications for pembrolizumab to include more patients with stage III-IVA cervical cancer. The U.S. Food...
Fam-trastuzumab deruxtecan-nxki was approved for HER2-positive tumors, regardless of the tissue of origin. The U.S. Food and Drug Administration...
The FDA has approved a new molecularly targeted therapeutic called duvelisib for treating certain patients with blood cancer. The...
The amount of residual tumor left after surgery is an important prognostic factor for ovarian cancer patient survival. A...
The FDA approved the immune checkpoint inhibitor, cemiplimab-rwlc, for certain patients with locally advanced or metastatic basal cell carcinoma—the...
A recent study reports that how pediatricians talk to parents can affect whether or not they chose to have...
Belzutifan is now available for certain patients with kidney cancer whether or not they have von Hippel-Lindau disease. The...